SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC — Stella

Recruiting

Back to TNBC - Triple-Negative Breast Cancer trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

West China Hospital, Sichuan University, Sichuan, Chengdu

Key details

Phase

Large-scale testing

Sponsor

West China Hospital

Enrollment target

~318 participants

Started

November 2024

Primary completion

November 2029

Age range

18 Years – 65 Years

Sex

Female only

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov